These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 2524762)

  • 1. [Survival in primary dilated cardiomyopathy as a function of tobacco smoking. A retrospective study].
    Juillière Y; Danchin N; Briançon S; Khalife K; Balaud A; Gilgenkrantz JM; Pernot C; Cherrier F
    Presse Med; 1989 Apr; 18(16):809-12. PubMed ID: 2524762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dobutamine-induced augmentation of left ventricular ejection fraction predicts survival of heart failure patients with severe non-ischaemic cardiomyopathy.
    Ramahi TM; Longo MD; Cadariu AR; Rohlfs K; Slade M; Carolan S; Vallejo E; Wackers FJ
    Eur Heart J; 2001 May; 22(10):849-56. PubMed ID: 11350094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dilated cardiomyopathy: long-term follow-up and predictors of survival.
    Juillière Y; Danchin N; Briançon S; Khalife K; Ethévenot G; Balaud A; Gilgenkrantz JM; Pernot C; Cherrier F
    Int J Cardiol; 1988 Dec; 21(3):269-77. PubMed ID: 3229865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Right ventricular function predicts transplant-free survival in idiopathic dilated cardiomyopathy.
    La Vecchia L; Varotto L; Zanolla L; Spadaro GL; Fontanelli A
    J Cardiovasc Med (Hagerstown); 2006 Sep; 7(9):706-10. PubMed ID: 16932086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of predictive factors of mortality in dilated cardiomyopathy. A cooperative study by the Cardiomyopathy Working Group].
    Komajda M; Jais JP; Goldfarb B; Bouhour JB; Juillières Y; Lanfranchi J; Peycelon P; Geslin P; Carrie D; Grosgogeat Y
    Arch Mal Coeur Vaiss; 1990 Jun; 83(7):899-906. PubMed ID: 2114849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dilated cardiomyopathy: a new natural history? The experience of the Italian Multicenter Cardiomyopathy Study (SPIC)].
    Gavazzi A; De Maria R; Porcu M; Beretta L; Casazza F; Castelli G; Luvini M; Parodi O; Recalcati F; Renosto G
    G Ital Cardiol; 1995 Sep; 25(9):1109-25. PubMed ID: 8529848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of cardiac stability after weaning from left ventricular assist devices in patients with idiopathic dilated cardiomyopathy.
    Dandel M; Weng Y; Siniawski H; Potapov E; Drews T; Lehmkuhl HB; Knosalla C; Hetzer R
    Circulation; 2008 Sep; 118(14 Suppl):S94-105. PubMed ID: 18824777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving survival rates of patients with idiopathic dilated cardiomyopathy in Tuscany over 3 decades: impact of evidence-based management.
    Castelli G; Fornaro A; Ciaccheri M; Dolara A; Troiani V; Tomberli B; Olivotto I; Gensini GF
    Circ Heart Fail; 2013 Sep; 6(5):913-21. PubMed ID: 23888044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced right ventricular ejection fraction as a marker for idiopathic dilated cardiomyopathy compared with ischemic left ventricular dysfunction.
    La Vecchia L; Zanolla L; Varotto L; Bonanno C; Spadaro GL; Ometto R; Fontanelli A
    Am Heart J; 2001 Jul; 142(1):181-9. PubMed ID: 11431676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A physiological oral magnesium supplement does not influence total serum magnesium, left ventricular ejection fraction and prognosis in patients with dilated cardiomyopathy.
    Fruhwald FM; Dusleag J; Fruhwald SM; Grisold M; Gasser R; Klein W
    Magnes Res; 1993 Sep; 6(3):251-5. PubMed ID: 8292499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors and predictors of in-hospital mortality of patients with heart failure with preserved left ventricular ejection fraction.
    Pérez de Isla L; Zamorano J; Hernández N; Contreras L; Rodrigo JL; Almería C; Aubele AL; Mataix L; Macaya C
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1011-5. PubMed ID: 18799963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: reappraisal of the role of programmed ventricular stimulation.
    Gatzoulis KA; Vouliotis AI; Tsiachris D; Salourou M; Archontakis S; Dilaveris P; Gialernios T; Arsenos P; Karystinos G; Sideris S; Kallikazaros I; Stefanadis C
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):504-12. PubMed ID: 23588627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early changes in right ventricular function and their clinical consequences in childhood and adolescent dilated cardiomyopathy.
    Grosse-Wortmann L; Roche SL; Yoo SJ; Seed M; Kantor P
    Cardiol Young; 2010 Aug; 20(4):418-25. PubMed ID: 20420745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recovery of normal ventricular function in patients with dilated cardiomyopathy: predictors of an increasingly prevalent clinical event.
    Binkley PF; Lesinski A; Ferguson JP; Hatton PS; Yamokoski L; Hardikar S; Cooke GE; Leier CV
    Am Heart J; 2008 Jan; 155(1):69-74. PubMed ID: 18082492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in mechanisms and outcomes of syncope in patients with coronary disease or idiopathic left ventricular dysfunction as assessed by electrophysiologic testing.
    Brembilla-Perrot B; Suty-Selton C; Beurrier D; Houriez P; Nippert M; de la Chaise AT; Louis P; Claudon O; Andronache M; Abdelaal A; Sadoul N; Juillière Y
    J Am Coll Cardiol; 2004 Aug; 44(3):594-601. PubMed ID: 15358027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up.
    Vrtovec B; Poglajen G; Lezaic L; Sever M; Domanovic D; Cernelc P; Socan A; Schrepfer S; Torre-Amione G; Haddad F; Wu JC
    Circ Res; 2013 Jan; 112(1):165-73. PubMed ID: 23065358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The prognostic assessment of dilated cardiomyopathy: a follow-up of 138 patients].
    Ciaccheri M; Castelli G; Nannini M; Santoro G; Troiani V; Di Lenarda A; Miani D; Sinagra G; Mestroni L; Risoli A
    G Ital Cardiol; 1990 Jul; 20(7):645-50. PubMed ID: 2245905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study.
    Masci PG; Schuurman R; Andrea B; Ripoli A; Coceani M; Chiappino S; Todiere G; Srebot V; Passino C; Aquaro GD; Emdin M; Lombardi M
    Circ Cardiovasc Imaging; 2013 Sep; 6(5):790-9. PubMed ID: 23934992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mortality of dilated myocardiopathies as a function of continuation of alcohol drinking. Multivariate analysis concerning 236 patients].
    Haissaguerre M; Fleury B; Gueguen A; Bonnet J; Lorente P; Nakache JP; Broustet JP; Dallochio M; Besse P
    Presse Med; 1989 Apr; 18(14):711-4. PubMed ID: 2524748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of changes over time in exercise capacity and echocardiographic measurements in patients with chronic heart failure.
    Florea VG; Henein MY; Anker SD; Francis DP; Chambers JS; Ponikowski P; Coats AJ
    Eur Heart J; 2000 Jan; 21(2):146-53. PubMed ID: 10637088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.